MBAEE- Ross School of Business, University of Michigan |
2009 |
|
Appointment Type |
Department |
Division |
Rank |
Secondary |
|
|
Professor |
Center |
Comprehensive Cancer Center |
Comprehensive Cancer Center |
Professor |
Center |
Ctr for Clinical & Translational Sci |
Ctr for Clinical & Translational Sci |
Professor |
Center |
Informatics Institute |
Informatics Institute |
Professor |
Primary |
Joint Pathology |
Molecular & Cellular Pathology |
Professor |
Center |
Nephrology Research & Training Center |
Nephrology Research & Training Center |
Professor |
|
Cancer Biology |
Genetics, Genomics and Bioinformatics |
|
Publication |
PUBMEDID |
Chakravarthi BVSK, Rodriguez Pena MDC, Agarwal S, Chandrashekar DS, Hodigere Balasubramanya SA, Jabboure FJ, Matoso A, Bivalacqua TJ, Rezaei K, Chaux A, Grizzle WE, Sonpavde G, Gordetsky J, Netto GJ, Varambally S. A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression. Neoplasia. 2018 Sep;20(9):894-904. |
30121007 |
Nam HY, Chandrashekar DS, Kundu A, Shelar S, Kho EY, Sonpavde G, Naik G, Ghatalia P, Livi CB, Varambally S*, Sudarshan S*.Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Mol Cancer Res. 2019 Jan;17(1):84-96. * Senior Authors. |
30131446 |
Chakravarthi BVSK, Chandrashekar DS, Hodigere Balasubramanya SA, Robinson AD, Carskadon S, Rao U, Gordetsky J, Manne U, Netto GJ, Sudarshan S, Palanisamy N, Varambally S.Wnt receptor Frizzled 8 is a target of ERG in prostate cancer. Prostate. 2018 Dec;78(16):1311-1320. |
30051493 |
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Rodriguez IP, Chakravarthi BVSK and Varambally S. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, N.Y.) 19(8):649-658. August 2017 http://ualcan.path.uab.edu |
28732212 |
Wang X, Qiao Y, Asangani IA, Ateeq B, Poliakov A, Cieślik M, Pitchiaya S, Chakravarthi BV, Cao X, Jing X, Wang CX, Apel IJ, Wang R, Tien JC, Juckette KM, Yan W, Jiang H, Wang S, Varambally S, Chinnaiyan AM. Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer. Cancer Cell. 2017 Apr 10;31(4):532-548.e7. |
28344039 |
Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BV, Varambally S, Tomlins SA, Nanus DM, Tagawa ST, Van Allen EM, Elemento O, Sboner A, Garraway LA, Rubin MA, Demichelis F. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016 Mar;22(3):298-305. |
26855148 |
Ende Zhao, Tomasz Maj, Ilona Kryczek, Wei Li, Ke Wu, Lili Zhao, Shuang, Wei, Joel Crespo, Shanshan Wan, Linda Vatan, Wojciech Szeliga, Yin Wang, Yan, Liu, Sooryanarayana Varambally, Arul M. Chinnaiyan, Theodore H. Welling, Victor E., Marquez, Jan Kotarski, Yi Zhang, Rebecca Liu, Guobin Wang, Weiping Zou, Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016 Jan;17(1):95-103. |
26523864 |
Wang R, Asangani I.A., Chakravarthi B.V.S.K., Ateeq B, Lonigro R.J., Cao Q., Mani R., Camacho D.F., McGregor N., Schumann T.E.W., Jing X., Menawat R., Tomlins S.A, Zheng H., Otte A.P., Mehra R., Siddiqui J., Dhanasekaran S.M., Nyati M.K., Pienta K.J., Palanisamy N., Kunju L.P., Rubin M.A.. Chinnaiyan A.M. and Varambally S. Role of Transcriptional Co-Repressor CtBP1 in Prostate Cancer Progression. Neoplasia. Oct. 2012, 14(10): 905-14. |
23097625 |
Cao Q, Mani RS, Ateeq B, Dhanasekaran SM, Asangani IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X, Wang R, Li Y, Dahiya A, Wang L, Pandhi M, Lonigro RJ, Wu YM, Tomlins SA, Palanisamy N, Qin Z, Yu J, Maher CA, Varambally S.* and Chinnaiyan A.M.* Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer. (*senior authors). Cancer Cell. 2011 Aug 16;20(2):187-99. PMCID: PMC3157014 |
21840484 |
Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner JC, Yu J, Kim JH, Han B, Tan P, Kumar-Sinha C, Lonigro RJ, Palanisamy N, Maher CA, Chinnaiyan AM. Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer. Science. 2008 Dec 12;322(5908):1695-9. PMCID:PMC2684823. |
19008416 |
Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM. Integrative Genomic and Proteomic Analysis of Prostate Cancer Reveals Signatures of Metastatic Progression. Cancer Cell. 2005 Nov;8(5):393-406. |
16286247 |
Varambally S, Dhanasekaran SM, Barrette TR, Sanda MG, Ghosh D, Pienta KJ, Sewalt RGAB, Otte AP, Rubin MA, Chinnaiyan AM. The Polycomb Group Protein EZH2 is involved in Prostate Cancer Progression. Nature, (2002) 419:624-9. |
11518967 |
|
|